We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.18B
AUM Growth
-$2.44B
Cap. Flow
-$2.85B
Cap. Flow %
-89.66%
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169
Avg Time Held Equity + Options
4.1 quarters
Top 10 Avg Time Held Equity + Options
0.1 quarters
Top 20 Avg Time Held Equity + Options
0.6 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.1 quarters
Top 20 Avg Time Held Equity only
0.6 quarters

Top Buys

Rank Stock Value
1
PXD icon
Pioneer Natural Resource Co.
PXD
+$604M
2
SPLK icon
Splunk Inc
SPLK
+$446M
3
HES icon
Hess
HES
+$339M
4
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$106M
5
X icon
US Steel
X
+$50.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.06B
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$887M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$371M
4
VMW
VMware, Inc
VMW
+$354M
5
NEWR
New Relic, Inc.
NEWR
+$284M

Sector Composition

Rank Sector Weight
1 Energy 29.51%
2 Technology 21.97%
3 Healthcare 10.49%
4 Miscellaneous 10.26%
5 Real Estate 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PLTR icon
376
Palantir
PLTR
$502B
$258K 0.01%
15,000
-22,500
-60% -$401K
2023 Q2
2 quarters
QQQ icon
377
PUT
Invesco QQQ Trust
QQQ
$499B
$252K 0.01%
+90,000
New +$34.2M
2023 Q4
0 quarters
GLUE icon
378
Monte Rosa Therapeutics
GLUE
$897M
$250K 0.01%
44,247
-41,231
-48% -$162K
2022 Q1
7 quarters
ALKS icon
379
Alkermes
ALKS
$6.75B
$244K 0.01%
+8,794
New +$228K
2023 Q4
0 quarters
BCYC icon
380
CALL
Bicycle Therapeutics
BCYC
$266M
$226K 0.01%
125,000
+101,500
+432% +$1.68M
2023 Q3
1 quarter
BKD icon
381
Brookdale Senior Living
BKD
$2.45B
$222K 0.01%
+38,166
New +$179K
2023 Q4
0 quarters
KRG icon
382
Kite Realty
KRG
$4.83B
$208K 0.01%
+9,102
New +$194K
2023 Q4
0 quarters
UBX icon
383
DELISTED
Unity Biotechnology
UBX
$179K 0.01%
92,700
-86,380
-48% -$161K
2022 Q3
5 quarters
HLN icon
384
Haleon
HLN
$41.8B
$177K 0.01%
21,500
-52,685
-71% -$434K
2022 Q3
5 quarters
MAT icon
385
CALL
Mattel
MAT
$4.79B
$170K 0.01%
+172,500
New +$3.36M
2023 Q4
0 quarters
BGS icon
386
PUT
B&G Foods
BGS
$198M
$160K 0.01%
225,000
+10,000
+5% +$92.6K
2023 Q1
3 quarters
AFMD icon
387
DELISTED
Affimed
AFMD
$159K 0.01%
25,494
-56,506
-69% -$234K
2023 Q2
2 quarters
CPRI icon
388
PUT
Capri Holdings
CPRI
$1.72B
$142K ﹤0.01%
13,900
– –
2021 Q2
10 quarters
ARGX icon
389
CALL
argenx
ARGX
$51.1B
$135K ﹤0.01%
+12,000
New +$5.59M
2023 Q4
0 quarters
IWM icon
390
CALL
iShares Russell 2000 ETF
IWM
$78.3B
$128K ﹤0.01%
30,000
-10,000
-25% -$1.79M
2023 Q2
2 quarters
APLS icon
391
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$119K ﹤0.01%
25,000
-25,000
-50% -$1.27M
2023 Q2
2 quarters
PTCT icon
392
CALL
PTC Therapeutics
PTCT
$5.25B
$119K ﹤0.01%
+50,000
New +$1.14M
2023 Q4
0 quarters
ADT icon
393
PUT
ADT
ADT
$4.71B
$116K ﹤0.01%
35,600
– –
2021 Q2
10 quarters
KVUE icon
394
CALL
Kenvue
KVUE
$34.2B
$116K ﹤0.01%
+130,000
New +$2.6M
2023 Q4
0 quarters
HOG icon
395
PUT
Harley-Davidson
HOG
$2.85B
$100K ﹤0.01%
250,000
– –
2023 Q3
1 quarter
SWTX icon
396
CALL
DELISTED
SpringWorks Therapeutics
SWTX
$99K ﹤0.01%
+30,000
New +$783K
2023 Q4
0 quarters
CONXW icon
397
DELISTED
CONX Corp. Warrant
CONXW
$98.6K ﹤0.01%
316,890
-143,328
-31% -$31.9K
2021 Q1
11 quarters
DTIL icon
398
Precision BioSciences
DTIL
$180M
$86.9K ﹤0.01%
7,937
-36,673
-82% -$395K
2022 Q2
6 quarters
MRNA icon
399
CALL
Moderna
MRNA
$85.3B
$85.5K ﹤0.01%
+12,000
New +$1.01M
2023 Q4
0 quarters
NBIX icon
400
CALL
Neurocrine Biosciences
NBIX
$14.4B
$85K ﹤0.01%
+10,000
New +$1.15M
2023 Q4
0 quarters
14 15
16
17 18

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2023 Portfolio in Review

As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

UBS O'Connor withdrew a net $2.85B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.

By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.

  • UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
  • UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
  • UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
  • UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
  • UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
  • UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.